[Diagnosis and treatment of basaloid squamous cell carcinoma of the esophagus].
OBJECTIVE
To investigate the histopathological features of basaloid squamous cell carcinoma of the esophagus, and to explore the ways of its diagnosis, differential diagnosis and treatment.


METHODS
The clinical data and pathological features of 23 cases of esophageal basaloid squamous cell carcinoma were reviewed and analyzed retrospectively.


RESULTS
The tumors were mainly located at the middle third segment of the esophagus. The 1-,2- and 3-year survival rates were 60.9%, 21.7% and 0, respectively.


CONCLUSIONS
The basaloid squamous cell carcinoma of the esophagus is highly malignant with poor prognosis. Radical resection combined with radiotherapy and chemotherapy is required.
Chen
Jian-Xiang
JX
Department of Radiotherapy, Zhejiang Provincial Cancer Hospital, Hangzhou 310022, China. chenjianxiang1968@126.com
Tang
Qiu
Q
Zhu
Hui-Neng
HN
Zheng
Yuan-Da
YD
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002281:Carcinoma, Basosquamous / Q000175:diagnosis* / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D016629:Esophagectomy / Q000379:methods; D004947:Esophagus / Q000473:pathology* / Q000601:surgery; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011882:Radiotherapy, High-Energy; D012189:Retrospective Studies; D015996:Survival Rate
D000970:Antineoplastic Agents; D002945:Cisplatin; D005472:Fluorouracil